GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:009706110 | Thyroid | PTC | dendritic spine organization | 47/5968 | 84/18723 | 4.27e-06 | 5.28e-05 | 47 |
GO:003424916 | Thyroid | PTC | negative regulation of cellular amide metabolic process | 122/5968 | 273/18723 | 5.50e-06 | 6.64e-05 | 122 |
GO:005076716 | Thyroid | PTC | regulation of neurogenesis | 156/5968 | 364/18723 | 5.86e-06 | 7.05e-05 | 156 |
GO:009026319 | Thyroid | PTC | positive regulation of canonical Wnt signaling pathway | 55/5968 | 106/18723 | 1.45e-05 | 1.55e-04 | 55 |
GO:00609994 | Thyroid | PTC | positive regulation of dendritic spine development | 27/5968 | 42/18723 | 1.58e-05 | 1.67e-04 | 27 |
GO:00610017 | Thyroid | PTC | regulation of dendritic spine morphogenesis | 29/5968 | 47/18723 | 2.44e-05 | 2.40e-04 | 29 |
GO:00609976 | Thyroid | PTC | dendritic spine morphogenesis | 35/5968 | 61/18723 | 3.41e-05 | 3.22e-04 | 35 |
GO:001714815 | Thyroid | PTC | negative regulation of translation | 108/5968 | 245/18723 | 3.75e-05 | 3.48e-04 | 108 |
GO:005196214 | Thyroid | PTC | positive regulation of nervous system development | 117/5968 | 272/18723 | 6.72e-05 | 5.89e-04 | 117 |
GO:00488139 | Thyroid | PTC | dendrite morphogenesis | 69/5968 | 146/18723 | 7.12e-05 | 6.19e-04 | 69 |
GO:00610033 | Thyroid | PTC | positive regulation of dendritic spine morphogenesis | 15/5968 | 20/18723 | 9.35e-05 | 7.73e-04 | 15 |
GO:00991738 | Thyroid | PTC | postsynapse organization | 77/5968 | 168/18723 | 1.01e-04 | 8.25e-04 | 77 |
GO:00109766 | Thyroid | PTC | positive regulation of neuron projection development | 75/5968 | 163/18723 | 1.06e-04 | 8.56e-04 | 75 |
GO:00519608 | Thyroid | PTC | regulation of nervous system development | 177/5968 | 443/18723 | 1.72e-04 | 1.32e-03 | 177 |
GO:00991754 | Thyroid | PTC | regulation of postsynapse organization | 45/5968 | 90/18723 | 2.57e-04 | 1.84e-03 | 45 |
GO:004592614 | Thyroid | PTC | negative regulation of growth | 105/5968 | 249/18723 | 3.76e-04 | 2.54e-03 | 105 |
GO:00507752 | Thyroid | PTC | positive regulation of dendrite morphogenesis | 22/5968 | 37/18723 | 4.92e-04 | 3.23e-03 | 22 |
GO:00303087 | Thyroid | PTC | negative regulation of cell growth | 80/5968 | 188/18723 | 1.28e-03 | 7.31e-03 | 80 |
GO:00331356 | Thyroid | PTC | regulation of peptidyl-serine phosphorylation | 62/5968 | 144/18723 | 3.05e-03 | 1.50e-02 | 62 |
GO:00488144 | Thyroid | PTC | regulation of dendrite morphogenesis | 32/5968 | 67/18723 | 4.75e-03 | 2.22e-02 | 32 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CAPRIN2 | SNV | Missense_Mutation | novel | c.1673N>G | p.Ser558Cys | p.S558C | Q6IMN6 | protein_coding | deleterious(0.04) | possibly_damaging(0.513) | TCGA-3C-AALI-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unspecific | Poly E | Complete Response |
CAPRIN2 | SNV | Missense_Mutation | | c.588N>C | p.Lys196Asn | p.K196N | Q6IMN6 | protein_coding | deleterious(0.02) | benign(0.27) | TCGA-A2-A0YK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cytoxan | SD |
CAPRIN2 | SNV | Missense_Mutation | novel | c.409N>A | p.Glu137Lys | p.E137K | Q6IMN6 | protein_coding | deleterious(0.01) | probably_damaging(0.998) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CAPRIN2 | SNV | Missense_Mutation | | c.587A>C | p.Lys196Thr | p.K196T | Q6IMN6 | protein_coding | deleterious(0) | possibly_damaging(0.784) | TCGA-AR-A0TS-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
CAPRIN2 | SNV | Missense_Mutation | | c.554N>T | p.Ser185Phe | p.S185F | Q6IMN6 | protein_coding | tolerated(0.12) | probably_damaging(0.992) | TCGA-C8-A1HM-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | doxorubicin | CR |
CAPRIN2 | SNV | Missense_Mutation | novel | c.1820C>T | p.Ser607Phe | p.S607F | Q6IMN6 | protein_coding | deleterious(0.04) | benign(0.023) | TCGA-UU-A93S-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
CAPRIN2 | insertion | In_Frame_Ins | novel | c.3125_3126insAGGATGTTATTTTATGTATTTTAA | p.Leu1042_Gln1043insGlyCysTyrPheMetTyrPheAsn | p.L1042_Q1043insGCYFMYFN | Q6IMN6 | protein_coding | | | TCGA-A8-A09Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD |
CAPRIN2 | insertion | Frame_Shift_Ins | novel | c.3123_3124insGTGAGCCTTATGATAA | p.Leu1042ValfsTer27 | p.L1042Vfs*27 | Q6IMN6 | protein_coding | | | TCGA-A8-A09Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD |
CAPRIN2 | deletion | Frame_Shift_Del | novel | c.1596delN | p.Met533CysfsTer27 | p.M533Cfs*27 | Q6IMN6 | protein_coding | | | TCGA-D8-A27V-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
CAPRIN2 | SNV | Missense_Mutation | novel | c.1175C>A | p.Ala392Glu | p.A392E | Q6IMN6 | protein_coding | tolerated(0.16) | benign(0.003) | TCGA-C5-A8ZZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unspecific | Cisplatin | SD |